Close

Production & Manufacturing

Prokarium and Probiomed Scale Up Manufacture of Oral Vaccines

Biotech firms Prokarium and Probiomed have announced a collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will...

Synpromics and GE Healthcare to collaborate to Extend the Toolbox for Production of Biologics

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will...

Xenikos awarded EUR 1 million innovation credit extension to support T-Guard(TM) development

Xenikos B.V focused on the development of innovative immunotherapies for the treatment of patients suffering from serious immune diseases or rejection after transplantation,  Announced that it has been awarded a EUR 1 million innovation credit extension...

Glass Solutions delivers high quality glassware for laboratory applications

Glass Solutions, a world leader in the manufacture of high quality, precision glassware, is the supplier of choice for a wide variety of laboratories, providing specialist scientific glassware backed by unrivalled service and support. With extensive...

Hikma announces agreement with Vectura for the development of generic salmeterol for the US market

Hikma Pharmaceuticals PLC the fast growing multinational pharmaceutical group, announces that it has, through its wholly owned US subsidiary West-Ward Pharmaceuticals, signed a development and licensing agreement with Vectura for its generic salmeterol product (VR730).   ...

Zuellig pharma collaborates with Taiko on Cleverin in Taiwan

Building on many years of partnership, Zuellig Pharma Taiwan and Taiko Pharmaceutical Limited have kicked off a new collaboration that will see Zuellig Pharma distribute and promote Cleverin in Taiwan.    Cleverin® is a leading Japanese...

Breckenridge Announces Entry into Injectable Market with the Immediate Launch of Methylergonovine Maleate Injection

Breckenridge Pharmaceutical, Inc. announced the immediate launch of Methylergonovine Maleate Injection, USP 0.2mg/mL. This product is an AP rated generic to Methergine®, a product owned by Edison Therapeutics, LLC. and is a semi-synthetic ergot alkaloid used for the prevention...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read